| |
|
|
 | Acesso ao texto completo restrito à biblioteca da Embrapa Amazônia Ocidental. Para informações adicionais entre em contato com cpaa.biblioteca@embrapa.br. |
|
Registro Completo |
|
Biblioteca(s): |
Embrapa Amapá; Embrapa Amazônia Ocidental. |
|
Data corrente: |
07/03/2022 |
|
Data da última atualização: |
17/11/2022 |
|
Tipo da produção científica: |
Artigo em Periódico Indexado |
|
Autoria: |
SEBASTIÃO, F. de A.; ROCHA, M. J. S.; BRANDÃO, F. R.; OLIVEIRA, M. I. B. de; SOUZA, D. C. de M; BARBOSA, B. C. do N.; MONTEIRO, P. C.; MAJOLO, C.; CRESCENCIO, R.; TAVARES-DIAS, M.; CHAGAS, E. C. |
|
Afiliação: |
FERNANDA DE ALEXANDRE SEBASTIÃO, FUNDAÇÃO DE AMPARO À PESQUISA DO ESTADO DO AMAZONAS - FAPEAM; MARIA JULIETE SOUZA ROCHA, UNIVERSIDADE FEDERAL DO AMAZONAS - UFAM; FRANMIR RODRIGUES BRANDÃO, FUNDAÇÃO DE AMPARO À PESQUISA DO ESTADO DO AMAZONAS - FAPEAM; MARIA INÊS BRAGA DE OLIVEIRA, UNIVERSIDADE FEDERAL DO AMAZONAS - UFAM; DAMY CAROLINE DE MELO SOUZA, UNIVERSIDADE FEDERAL DO AMAZONAS - UFAM; BRUNA CARLOS DO NASCIMENTO BARBOSA, UNINORTE LAUREATE INTERNATIONAL UNIVERSITIES; PATRÍCIA CASTRO MONTEIRO, SECRETARIA MUNICIPAL DE EDUCAÇÃO - MANAUS; CLAUDIA MAJOLO, CPAA; ROGER CRESCENCIO, CPAA; MARCOS TAVARES DIAS, CPAF-AP; EDSANDRA CAMPOS CHAGAS, CPAA. |
|
Título: |
Evaluation of the clinical safety and efficacy of fenbendazole and levamisole in the control of Neoechinorhynchus buttnerae in Colossoma macropomum: Acanthocephalosis treatments. |
|
Ano de publicação: |
2022 |
|
Fonte/Imprenta: |
Aquaculture International, v. 30, p. 1341-1351, 2022. |
|
DOI: |
https://doi.org/10.1007/s10499-022-00854-2 |
|
Idioma: |
Inglês |
|
Conteúdo: |
Occurrences of parasitic infections caused by Neoechinorhynchus buttnerae in Colossoma macropomum (tambaqui), especially in the northern region of Brazil, have increased in the
past two decades and have caused economic losses in tambaqui production. The aim of this study was to evaluate the in vivo efcacy and clinical safety of fenbendazole and levamisole in controlling and treating N. buttnerae in tambaqui for 30 days. Juvenile tambaqui naturally infected with N. buttnerae were distributed in 15 tanks (n = 12 per 1,000 L-tank),
constituting fve treatments, in triplicate. Treatments were administered via diet (mg kg - 1 of live weight): control (0 mg kg - 1), F1 (100 mg kg - 1 of fenbendazole), F2 (200 mg kg - 1 of fenbendazole), L1 (200 mg kg - 1 of levamisole), and L2 (300 mg kg - 1 of levamisole). Fish survival rate was 100% during the entire experimental period. Fenbendazole treatments were not efective against N. buttnerae; however, L1 and L2 showed efcacy of 73.4 and 99.15%, respectively. Treatments with fenbendazole or levamisole did not afect the growth parameters of tambaqui. F1 and F2 showed signifcant reduction in the hemato- crit values when compared to L1, and hemoglobin values were signifcantly reduced in F1 when compared to L1, L2, and the control group. There were no signifcant diferences in RBC, MCV, and CHCM. The plasma glucose value was statistically lower in F1 than in the L1 (p = 0.03) and L2 (p = 0.02) treatments. For alanine aminotransferase, there was a signifcant reduction (p = 0.004) in the F1 and F2 groups compared to the L2 group. No statistical diference was observed for aspartate aminotransferase among the treatments. More studies are warranted to further evaluate other therapeutic strategies using shorter periods for controlling and efciently treating N. buttnerae. MenosOccurrences of parasitic infections caused by Neoechinorhynchus buttnerae in Colossoma macropomum (tambaqui), especially in the northern region of Brazil, have increased in the
past two decades and have caused economic losses in tambaqui production. The aim of this study was to evaluate the in vivo efcacy and clinical safety of fenbendazole and levamisole in controlling and treating N. buttnerae in tambaqui for 30 days. Juvenile tambaqui naturally infected with N. buttnerae were distributed in 15 tanks (n = 12 per 1,000 L-tank),
constituting fve treatments, in triplicate. Treatments were administered via diet (mg kg - 1 of live weight): control (0 mg kg - 1), F1 (100 mg kg - 1 of fenbendazole), F2 (200 mg kg - 1 of fenbendazole), L1 (200 mg kg - 1 of levamisole), and L2 (300 mg kg - 1 of levamisole). Fish survival rate was 100% during the entire experimental period. Fenbendazole treatments were not efective against N. buttnerae; however, L1 and L2 showed efcacy of 73.4 and 99.15%, respectively. Treatments with fenbendazole or levamisole did not afect the growth parameters of tambaqui. F1 and F2 showed signifcant reduction in the hemato- crit values when compared to L1, and hemoglobin values were signifcantly reduced in F1 when compared to L1, L2, and the control group. There were no signifcant diferences in RBC, MCV, and CHCM. The plasma glucose value was statistically lower in F1 than in the L1 (p = 0.03) and L2 (p = 0.02) treatments. For alanine aminotransferase, there was... Mostrar Tudo |
|
Palavras-Chave: |
Acantocephalan; Antiparasitic treatment; Neoechinorhynchus buttnerae. |
|
Thesagro: |
Colossoma Macropomum; Peixe de Água Doce; Tambaqui; Verminose. |
|
Categoria do assunto: |
--
L Ciência Animal e Produtos de Origem Animal |
|
Marc: |
LEADER 02940naa a2200337 a 4500
001 2147165
005 2022-11-17
008 2022 bl uuuu u00u1 u #d
024 7 $ahttps://doi.org/10.1007/s10499-022-00854-2$2DOI
100 1 $aSEBASTIÃO, F. de A.
245 $aEvaluation of the clinical safety and efficacy of fenbendazole and levamisole in the control of Neoechinorhynchus buttnerae in Colossoma macropomum$bAcanthocephalosis treatments.$h[electronic resource]
260 $c2022
520 $aOccurrences of parasitic infections caused by Neoechinorhynchus buttnerae in Colossoma macropomum (tambaqui), especially in the northern region of Brazil, have increased in the past two decades and have caused economic losses in tambaqui production. The aim of this study was to evaluate the in vivo efcacy and clinical safety of fenbendazole and levamisole in controlling and treating N. buttnerae in tambaqui for 30 days. Juvenile tambaqui naturally infected with N. buttnerae were distributed in 15 tanks (n = 12 per 1,000 L-tank), constituting fve treatments, in triplicate. Treatments were administered via diet (mg kg - 1 of live weight): control (0 mg kg - 1), F1 (100 mg kg - 1 of fenbendazole), F2 (200 mg kg - 1 of fenbendazole), L1 (200 mg kg - 1 of levamisole), and L2 (300 mg kg - 1 of levamisole). Fish survival rate was 100% during the entire experimental period. Fenbendazole treatments were not efective against N. buttnerae; however, L1 and L2 showed efcacy of 73.4 and 99.15%, respectively. Treatments with fenbendazole or levamisole did not afect the growth parameters of tambaqui. F1 and F2 showed signifcant reduction in the hemato- crit values when compared to L1, and hemoglobin values were signifcantly reduced in F1 when compared to L1, L2, and the control group. There were no signifcant diferences in RBC, MCV, and CHCM. The plasma glucose value was statistically lower in F1 than in the L1 (p = 0.03) and L2 (p = 0.02) treatments. For alanine aminotransferase, there was a signifcant reduction (p = 0.004) in the F1 and F2 groups compared to the L2 group. No statistical diference was observed for aspartate aminotransferase among the treatments. More studies are warranted to further evaluate other therapeutic strategies using shorter periods for controlling and efciently treating N. buttnerae.
650 $aColossoma Macropomum
650 $aPeixe de Água Doce
650 $aTambaqui
650 $aVerminose
653 $aAcantocephalan
653 $aAntiparasitic treatment
653 $aNeoechinorhynchus buttnerae
700 1 $aROCHA, M. J. S.
700 1 $aBRANDÃO, F. R.
700 1 $aOLIVEIRA, M. I. B. de
700 1 $aSOUZA, D. C. de M
700 1 $aBARBOSA, B. C. do N.
700 1 $aMONTEIRO, P. C.
700 1 $aMAJOLO, C.
700 1 $aCRESCENCIO, R.
700 1 $aTAVARES-DIAS, M.
700 1 $aCHAGAS, E. C.
773 $tAquaculture International$gv. 30, p. 1341-1351, 2022.
Download
Esconder MarcMostrar Marc Completo |
|
Registro original: |
Embrapa Amapá (CPAF-AP) |
|
|
Biblioteca |
ID |
Origem |
Tipo/Formato |
Classificação |
Cutter |
Registro |
Volume |
Status |
URL |
Voltar
|
|
|
| Registros recuperados : 6 | |
| 4. |  | ARAÚJO, F. R.; MADRUGA, C. R.; RAMOS, C. A. do N.; MELO, E. S. de P.; ALMEIDA, M. C. de; FRAGOSO, S. P.; KESSLER, R. H.; SOARES, C. O.; OLIVEIRA, M. B.; ONSELEN, J. van. Imunização de bovinos com MSP1a e MSP2 recombinantes de Anaplasma marginale com CpG ODN 2006 como adjuvante, e desafio com isolado heterólogo. In: SÉRIES Embrapa: [coletânea de publicações seriadas da Embrapa Gado de Corte - 2006 - 2007 -2008]. Campo Grande, MS: Embrapa Gado de Corte, 2009. 27 p. 1 CD-ROM. (Embrapa Gado de Corte. Boletim de pesquisa e desenvolvimento, 19)| Biblioteca(s): Embrapa Gado de Corte. |
|    |
| 5. | | MELO, E. S. de P.; SOUZA, I. I. F.; RAMOS, C. A. N.; OSÓRIO, A. L. A. R.; JORGE, K. S. G.; ROSA, P. M. G.; RUSSI, L. S.; FARIAS, T. A.; ARAUJO, F. R. Avaliação preliminar de proteínas recombinantes de Mycobacterium bovis em teste de tuberculinização intradérmica em cobaios (Cavia porcellus). In: JORNADA CIENTÍFICA EMBRAPA GADO DE CORTE, 7., 2011, CAMPO GRANDE, MS. [Anais da]... Campo Grande, MS: Embrapa Gado de Corte, 2011.| Tipo: Resumo em Anais de Congresso |
| Biblioteca(s): Embrapa Gado de Corte. |
| |
| 6. | | MADRUGA, C. R.; ARAÚJO, F. R. de; SOARES, C. O.; MELO, E. S. de P.; ALMEIDA, D. A.; ALMEIDA JÚNIOR, N. F. de; XAVIER, M. A. S.; OSÓRIO, A. L. A.; GÓES-CAVALCANTE, G.; RAMOS, C. A. do N. Diagnóstico molecular e análise filogenética de isolados brasileiros de Trypanosoma vivax baseado na reação da polimerase em cadeia - PCR. Campo Grande: Embrapa Gado de Corte, 2003. 5 p. (Embrapa Gado de Corte. Comunicado Técnico, 84). CNPGC.| Biblioteca(s): Embrapa Gado de Corte. |
| |
| Registros recuperados : 6 | |
|
| Expressão de busca inválida. Verifique!!! |
|
|
